Filing Details
- Accession Number:
- 0001181431-11-011420
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-18 13:44:54
- Reporting Period:
- 2011-01-21
- Filing Date:
- 2011-02-18
- Accepted Time:
- 2011-02-18 13:44:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1036968 | Diadexus Inc. | DDXS | Pharmaceutical Preparations (2834) | 943236309 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1134270 | Burrill & Co Llc | One Embarcadero Center, Suite 2700 San Francisco CA 94111 | No | No | Yes | No | |
| 1198177 | Steven Burrill | One Embarcadero Center, Suite 2700 San Francisco CA 94111 | No | No | Yes | No | |
| 1204411 | Burrill Life Sciences Capital Fund Lp | One Embarcadero Center, Suite 2700 San Francisco CA 94111 | No | No | Yes | No | |
| 1397090 | Burrill & Co (Indiana Gp), Llc | One Embarcadero Center, Suite 2700 San Francisco CA 94111 | No | No | Yes | No | |
| 1397091 | Burrill Indiana Life Sciences Capital Fund, L.p. | One Embarcadero Center, Suite 2700 San Francisco CA 94111 | No | No | Yes | No | |
| 1397093 | Burrill & Co (Life Sciences Gp), Llc | One Embarcadero Center, Suite 2700 San Francisco CA 94111 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-01-21 | 55,500 | $0.40 | 5,355,387 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-01-24 | 100,000 | $0.40 | 5,455,387 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-01-28 | 13,000 | $0.38 | 5,468,387 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-02-01 | 15,300 | $0.39 | 5,483,687 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-02-02 | 15,000 | $0.40 | 5,498,687 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-02-03 | 15,287 | $0.40 | 5,513,974 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-02-07 | 5,000 | $0.40 | 5,518,974 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The securities ("Securities") constitute the common stock of diaDexus, Inc. (the "Company") directly held by Burrill Life Sciences Capital Fund, L.P., a Delaware limited partnership ("BLSCF"), and by Burrill Indiana Life Sciences Capital Fund, L.P., a Delaware limited partnership ("BILSCF") in the amounts set forth in footnotes 3 through 9. BLSCF and BILSCF operate together as if they are a single fund. All Securities listed in this Form 4 also represent shares indirectly held by BLSGP, BIGP, Burrill and BLLC, as each are defined below.
- Burrill & Company (Life Sciences GP), LLC ("BLSGP") and Burrill & Company (Indiana GP), LLC ("BIGP") are the general partners of BLSCF and BILSCF, respectively. G. Steven Burrill ("Burrill") controls Burrill & Company LLC ("BCLLC"), which controls BLSGP and BIGP; thus Burrill ultimately holds the power to vote and dispose of the equity interests of both BLSGP and BIGP. BLSCF, BILSCF, BLSGP, BIGP, BCLLC, and Burrill (the "Reporting Persons") are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934. Each Reporting Person disclaims beneficial ownership of the Securities, except to the extent of its pecuniary interest therein.
- Represent 53,087 shares directly held by BLSCF, 2,413 shares directly held by BILSCF, and 55,500 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- Represent 95,652 shares directly held by BLSCF, 4,348 shares directly held by BILSCF, and 100,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- Represent 12,435 shares directly held by BLSCF, 565 shares directly held by BILSCF, and 13,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- Represent 14,635 shares directly held by BLSCF, 665 shares directly held by BILSCF, and 15,300 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- Represent 14,348 shares directly held by BLSCF, 652 shares directly held by BILSCF, and 15,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- Represent 14,622 shares directly held by BLSCF, 665 shares directly held by BILSCF, and 15,287 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- Represent 4,783 shares directly held by BLSCF, 217 shares directly held by BILSCF, and 5,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
Billionaire Hedge Funds
